These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9389388)

  • 1. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study.
    Mukherjee J; Yang ZY
    Eur J Pharmacol; 1997 Oct; 337(1):111-4. PubMed ID: 9389388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study.
    Mukherjee J; Yang ZY
    Synapse; 1999 Mar; 31(4):285-9. PubMed ID: 10051109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(6-18F-fluorohexyl)-N-methylpropargylamine: a fluorine-18-labeled monoamine oxidase B inhibitor for potential use in PET studies.
    Mukherjee J; Yang ZY; Lew R
    Nucl Med Biol; 1999 Jan; 26(1):111-6. PubMed ID: 10096510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.
    Holt A; Baker GB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):17-24. PubMed ID: 8832583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening and radioligand binding studies reveal monoamine oxidase-B as the primary binding target for d-deprenyl.
    Lesniak A; Aarnio M; Jonsson A; Norberg T; Nyberg F; Gordh T
    Life Sci; 2016 May; 152():231-7. PubMed ID: 27058977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A.
    Mukherjee J; Yang ZY
    Nucl Med Biol; 1999 Aug; 26(6):619-25. PubMed ID: 10587099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes.
    Levant B; Grigoriadis DE; DeSouza EB
    Eur J Pharmacol; 1993 Jul; 246(2):171-8. PubMed ID: 8104153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).
    Leonardi ET; Azmitia EC
    Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: an in vitro and in vivo study.
    Mukherjee J; Das MK; Yang ZY; Lew R
    Nucl Med Biol; 1998 Oct; 25(7):605-10. PubMed ID: 9804041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis.
    Dhami KS; Churchward MA; Baker GB; Todd KG
    J Neurochem; 2019 Mar; 148(6):761-778. PubMed ID: 30613984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.